Maravai Lifesciences Holdings (MRVI) Net Margin (2020 - 2026)
Maravai Lifesciences Holdings' (MRVI) quarterly Net Margin came in at 9.69% in Q1 2026, up 10313.0% year-on-year from N/an in Q1 2025, and up 92.34% quarter-over-quarter from 126.37% in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Net Margin (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Net Margin history runs 7 years deep, the most recent figure standing at 9.69% for Q1 2026.
- On a quarterly basis, Net Margin rose 10313.0% year-over-year to 9.69% in Q1 2026; TTM through Mar 2026 was 90.01%, a 2981.0% increase from a year earlier, with the FY2025 full-year figure at 124.24%, down 2407.0% from the prior year.
- Net Margin rose to 9.69% in Q1 2026 per MRVI's latest filing, from 126.37% in the prior quarter.
- Across five years, Net Margin topped out at 64.57% in Q2 2022 and bottomed at 249.84% in Q3 2024.
- The 5-year median for Net Margin is 26.53% (2024), against an average of 51.06%.
- Across the five-year window, Net Margin tumbled 22726 bps in 2024 and jumped 14161 bps in 2025, its largest moves.
- Year by year, Net Margin stood at 42.71% in 2022, then plunged by 447 bps to 148.34% in 2023, then soared by 45 bps to 81.45% in 2024, then tumbled by 55 bps to 126.37% in 2025, then soared by 92 bps to 9.69% in 2026.
- Per Business Quant, the three latest MRVI Net Margin figures stand at 9.69% (Q1 2026), 126.37% (Q4 2025), and 108.23% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | -9.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.69% |
| Dec 31, 2025 | -126.37% |
| Sep 30, 2025 | -108.23% |
| Jun 30, 2025 | -147.34% |
| Mar 31, 2025 | -112.81% |
| Dec 31, 2024 | -81.45% |
| Sep 30, 2024 | -249.84% |
| Jun 30, 2024 | -26.53% |
| Mar 31, 2024 | -35.34% |
| Dec 31, 2023 | -148.34% |
| Sep 30, 2023 | -22.59% |
| Jun 30, 2023 | -17.33% |
| Mar 31, 2023 | -1.71% |
| Dec 31, 2022 | 42.71% |
| Sep 30, 2022 | 52.10% |
| Jun 30, 2022 | 64.57% |
| Mar 31, 2022 | 60.12% |
| Dec 31, 2021 | 55.64% |
| Sep 30, 2021 | 64.54% |
| Jun 30, 2021 | 61.76% |